Hatch G. Sen. Orrin

Opinion: To Keep Drug Costs Low, Think Competition, Not Price Controls
A robust, competitive market is the best way to promote innovation and reduce prices

Even in today’s highly partisan environment, there’s one thing nearly all Americans agree on: The soaring cost of prescription drugs is alarming.

In fact, 80 percent of Americans consider the cost of prescription drugs unreasonable. At the same time, a majority of Americans recognize that prescription drugs have improved countless lives. The president’s recently unveiled comprehensive blueprint to lower prescription drug costs has many ideas worthy of exploration. However, if we truly want to reduce costs and make life-changing and life-saving medications accessible to all Americans, we must increase competition among prescription drugs — particularly new drugs that have the ability to cure diseases, but face limited competition.

Opinion: A Necessary Turning Point on Judicial Confirmations
Nominees should be debated on the merits


There are few duties of the United States Senate as solemn, and as consequential, as the consideration and confirmation of judicial nominees. Attention in the media is often focused on the Supreme Court, and for good reason, given how powerful the Supreme Court remains.